aTYR PHARMA INC — Director's Dealing 2022

Apr 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: aTYR PHARMA INC (LIFE)
CIK: 0001339970
Period of Report: 2022-04-26

Reporting Person: COUGHLIN TIMOTHY (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-04-26	Restricted Stock Units	$	A	6000	Acquired		Common Stock (6000)	Direct

Footnotes

F1: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F2: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.